Pediatric Nephrology

61 – 70 of 142

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/organization/v1001058?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
6
7
8
9
…
15
next »

2013
Mark Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab
Besbas, Nesrin ; Gulhan, Bora ; Karpman, Diana ^LU ; Topaloglu, Rezan ; Duzova, Ali ; Korkmaz, Emine and Ozaltin, Fatih (2013) In Pediatric Nephrology 28(1). p.155-158
- Contribution to journal › Article
Mark Ouabain Protects against Shiga Toxin-Triggered Apoptosis by Reversing the Imbalance between Bax and Bcl-xL
Burlaka, Ievgeniia ; Liu, Xiao Li ; Rebetz, Johan ^LU ; Arvidsson, Ida ^LU ; Yang, Liping ; Brismar, Hjalmar ; Karpman, Diana ^LU and Aperia, Anita (2013) In Journal of the American Society of Nephrology 24(9). p.1413-1423
- Contribution to journal › Article
Mark Eculizumab in an anephric patient with atypical haemolytic uraemic syndrome and advanced vascular lesions.
Békassy, Zivile ^LU ; Kristoffersson, Ann-Charlotte ^LU ; Cronqvist, Mats ^LU ; Roumenina, Lubka T ; Rybkine, Tania ; Vergoz, Laura ; Hue, Christophe ; Fremeaux-Bacchi, Veronique and Karpman, Diana ^LU (2013) In Nephrology Dialysis Transplantation 28(11). p.2899-2907
- Contribution to journal › Article
Mark Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome
Legendre, C. M. ; Licht, C. ; Muus, P. ; Greenbaum, L. A. ; Babu, S. ; Bedrosian, C. ; Bingham, C. ; Cohen, D. J. ; Delmas, Y. and Douglas, K. , et al. (2013) In New England Journal of Medicine 368(23). p.2169-2181
- Contribution to journal › Article
2012
Mark Escherichia coli O104:H4 and Hemolytic Uremic Syndrome: The Analysis Begins
Tarr, Phillip I. and Karpman, Diana ^LU (2012) In Clinical Infectious Diseases 55(6). p.760-763
- Contribution to journal › Debate/Note/Editorial
Mark Management of Shiga toxin-associated Escherichia coli-induced haemolytic uraemic syndrome: randomized clinical trials are needed
Karpman, Diana ^LU (2012) In Nephrology Dialysis Transplantation 27(10). p.3669-3674
- Contribution to journal › Debate/Note/Editorial
Mark The Antimicrobial Peptide Cathelicidin Protects Mice from Escherichia coli O157:H7-Mediated Disease.
Chromek, Milan ^LU ; Arvidsson, Ida ^LU and Karpman, Diana ^LU (2012) In PLoS ONE 7(10).
- Contribution to journal › Article
Mark A Novel C3 Mutation Causing Increased Formation of the C3 Convertase in Familial Atypical Hemolytic Uremic Syndrome.
Sartz, Lisa ^LU ; Olin, Anders ^LU ; Kristoffersson, Ann-Charlotte ^LU ; Ståhl, Anne-lie ^LU ; Johansson, Martin E ; Westman, Kerstin ^LU ; Fremeaux-Bacchi, Veronique ; Nilsson, Kristina and Karpman, Diana ^LU (2012) In Journal of immunology 188(4). p.2030-2037
- Contribution to journal › Article
Mark Shiga toxin pathogenesis : kidney complications and renal failure
Obrig, Tom G and Karpman, Diana ^LU (2012) In Current Topics in Microbiology and Immunology 357. p.36-105
- Contribution to journal › Article
2011
Mark Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome.
Ståhl, Anne-lie ^LU ; Sartz, Lisa ^LU and Karpman, Diana ^LU (2011) In Blood 117. p.5503-5513
- Contribution to journal › Article

« previous
1
…
6
7
8
9
…
15
next »